Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor
- PMID: 9242708
- DOI: 10.1074/jbc.272.32.20275
Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor
Abstract
Uterine growth factors are potential effector molecules in embryo growth signaling pathways. Pig uterine luminal flushings contained a heparin-binding growth factor (HBGF) that required 0.8 M NaCl for elution from heparin columns and was termed HBGF-0.8. This factor, which was heat- and acid-labile and of Mr 10,000 as assessed by gel filtration, stimulated DNA synthesis in fibroblasts and smooth muscle cells but not endothelial cells. Two forms of HBGF-0.8, termed HBGF-0.8-P1 and HBGF-0.8-P2, exhibited differential heparin-binding properties. SDS-polyacrylamide gel electrophoresis showed that each form of HBGF-0.8 migrated with an apparent Mr of 10, 000 under reducing conditions. Amino acid sequencing revealed the N-terminal sequence EENIKKGKKXIRTPKI for HBGF-0.8-P1 and ENIKKGKKXIRT for HBGF-0.8-P2. These sequences corresponded, respectively, to residues 247-262 and 248-259 of the 349-residue predicted primary translation product of porcine connective tissue growth factor (pCTGF). 10-kDa CTGF-mediated fibroblast DNA synthesis was modulated by exogenous heparin, and CTGF-immunoreactive proteins of 10, 16, and 20 kDa were present in unfractionated uterine luminal flushings. These data reveal the identity of a novel growth factor in uterine fluids as a highly truncated form of CTGF and show that the N-terminal two-thirds of the CTGF primary translation product is not required for mitogenic activity or heparin binding.
Similar articles
-
Characterization of 16- to 20-kilodalton (kDa) connective tissue growth factors (CTGFs) and demonstration of proteolytic activity for 38-kDa CTGF in pig uterine luminal flushings.Biol Reprod. 1998 Oct;59(4):828-35. doi: 10.1095/biolreprod59.4.828. Biol Reprod. 1998. PMID: 9746732
-
Purification of heparin-binding epidermal growth factor-like growth factor from pig uterine luminal flushings, and its production by endometrial tissues.Biol Reprod. 1995 Mar;52(3):561-71. doi: 10.1095/biolreprod52.3.561. Biol Reprod. 1995. PMID: 7538797
-
A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence.Biochem Biophys Res Commun. 1989 Dec 29;165(3):1096-103. doi: 10.1016/0006-291x(89)92715-0. Biochem Biophys Res Commun. 1989. PMID: 2610682
-
Purification and characterization of heparin-binding growth factors from porcine uterus.Biochem J. 1990 Feb 15;266(1):273-82. doi: 10.1042/bj2660273. Biochem J. 1990. PMID: 2310377 Free PMC article.
-
Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts.Cytokine Growth Factor Rev. 1997 Sep;8(3):171-9. doi: 10.1016/s1359-6101(97)00010-5. Cytokine Growth Factor Rev. 1997. PMID: 9462483 Review.
Cited by
-
Structural insights into regulation of CCN protein activities and functions.J Cell Commun Signal. 2023 Jun;17(2):371-390. doi: 10.1007/s12079-023-00768-5. Epub 2023 May 28. J Cell Commun Signal. 2023. PMID: 37245184 Free PMC article. Review.
-
Cooperation is the key: the CCN biological system as a gate to high complex protein superfamilies' signaling.J Cell Commun Signal. 2023 Jun;17(2):233-253. doi: 10.1007/s12079-023-00749-8. J Cell Commun Signal. 2023. PMID: 37166690 Free PMC article.
-
The investigation of hippo signaling pathway in mouse uterus during peri-implantation period.Arch Gynecol Obstet. 2023 Jun;307(6):1795-1809. doi: 10.1007/s00404-022-06660-8. Epub 2022 Jun 16. Arch Gynecol Obstet. 2023. PMID: 35708783
-
Hippo Signaling in the Endometrium.Int J Mol Sci. 2022 Mar 31;23(7):3852. doi: 10.3390/ijms23073852. Int J Mol Sci. 2022. PMID: 35409214 Free PMC article. Review.
-
The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.BMC Ophthalmol. 2022 Feb 10;22(1):63. doi: 10.1186/s12886-022-02303-3. BMC Ophthalmol. 2022. PMID: 35139812 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous